The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder

Frontiers in Genetics

Volumn 4, Issue JAN, 2013, Pages

  Joyce, Peter R ^a   Stephenson, John ^b   Kennedy, Martin ^a   Mulder, Roger T ^a   McHugh, Patrick C ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

5 HT; Depression; Dopamine; Genetics; Personality disorder

Indexed keywords

DOPAMINE TRANSPORTER; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BORDERLINE STATE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84893670056     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00313     Document Type: Article

References (52)

1. Bennett, A. J., Lesch, K. P., Heils, A., Long, J. C., Lorenz, J. G., Shoaf, S. E., et al. (2002). Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry 7, 118-122. doi: 10.1038/sj.mp.4000949
2. Black, D. W., Blum, N., Pfohl, B., and Hale, N. (2004). Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J. Pers. Disord. 18, 226-239. doi: 10.1521/pedi.18.3.226.35445
3. Brown, G. L., Ebert, M. H., Goyer, P. F., Jimerson, D. C., Klein, W. J., Bunney, W. E., et al. (1982). Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am. J. Psychiatry 139, 741-746.
4. Ciulla, T. A., Sklar, R. M., and Hauser, S. L. (1988). A simple method for DNA purification from peripheral blood. Anal. Biochem. 174, 485-488. doi: 10.1016/0003-2697(88)90047-4
5. Czesak, M., Le Francois, B., Millar, A. M., Deria, M., Daigle, M., Visvader, J. E., et al. (2012). Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (deaf-1) gene knock-out mice. J. Biol. Chem. 287, 6615-6627. doi: 10.1074/jbc. M111.293027
6. Derogatis, L. R., Lipman, R. S., and Covi, L. (1973). SCL-90: an outpatient psychiatric rating scale: preliminary report. Psychopharmacol. Bull. 9, 913-928.
7. Distel, M. A., Hottenga, J. J., Trull, T. J., and Boomsma, D. I. (2008a). Chromosome 9: linkage for borderline personality disorder features. Psychiatric Genet. 18, 302-307. doi: 10.1097/YPG.0b013e3283118468
8. Distel, M. A., Trull, T. J., Derom, C. A., Thiery, E. W., Grimmer, M. A., Martin, N. G., et al. (2008b). Heritability of borderline personality disorder features is similar across three countries. Psychol. Med. 38, 1219-1229. doi: 10.1017/S0033291707002024
9. First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). American Psychiatric Press.
10. Friedel, R. O. (2004). Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacology 29, 1029-1039. doi: 10.1038/sj.npp.1300424
11. Gabbard, G. O. (2005). Mind, brain, and personality disorders. Am. J. Psychiatry 162, 648-655. doi: 10.1176/appi.ajp.162.4.648
12. Giegling, I., Moreno-De-Luca, D., Rujescu, D., Schneider, B., Hartmann, A. M., Schnabel, A., et al. (2008). Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147, 308-315. doi: 10.1002/ajmg.b.30599
13. Goodman, M., New, A., and Siever, L. (2004). Trauma, genes, and the neurobiology of personality disorders. Ann. N.Y. Acad. Sci. 1032, 104-106. doi: 10.1196/annals.1314.008
14. Guitart-Masip, M., Pascual, J. C., Carmona, S., Hoekzema, E., Berge, D., Perez, V., et al. (2009). Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 1537-1545. doi: 10.1016/j.pnpbp.2009.08.022
15. Hamilton, M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 2356-2362. doi: 10.1136/jnnp.23.1.56
16. Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., et al. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychol. Med. 32, 935-941. doi: 10.1017/S0033291702005445
17. Herpertz, S. C., Dietrich, T. M., Wenning, B., Krings, T., Erberich, S. G., Willmes, K., et al. (2001). Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol. Psychiatry 50, 292-298. doi: 10.1016/S0006-3223(01)01075-7
18. Hollander, E., Stein, D. J., DeCaria, C. M., Cohen, L., Saoud, J. B., Skodol, A. E., et al. (1994). Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am. J. Psychiatry 151, 277-280. doi: 10.1176/appi.ajp.2013.12040518
19. Hyman, S. E. (2002). A new beginning for research on borderline personality disorder. Biol. Psychiatry 51, 933-935. doi: 10.1016/S0006-3223(02)01408-7
20. Joyce, P. J., McHugh, P. C., Light, K. J., Rowe, S., Miller, A., and Kennedy, M. A. (2009). The relationships between angry-impulsive personality traits, borderline personality disorder and genetic polymorphism of the dopamine transporter. Biol. Psychiatry 66, 717-721. doi: 10.1016/j.biopsych.2009.03.005
21. Joyce, P. R., McHugh, P. C., McKenzie, J. M., Sullivan, P. F., Mulder, R. T., Luty, S. E., et al. (2006). A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychol. Med. 36, 807-813. doi: 10.1017/S0033291706007288
22. Joyce, P. R., Mulder, R. T., Luty, S. E., Sullivan, P. F., McKenzie, J. M., Abbott, R. M., et al. (2002). Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust. N.Z. J. Psychiatry 36, 384-391. doi: 10.1046/j.1440-1614.2001.01026.x
23. Leyton, M., Okazawa, H., Diksic, M., Paris, J., Rosa, P., Mzengeza, S., et al. (2001). Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 158, 775-782. doi: 10.1176/appi.ajp.158.5.775
24. Loranger, A. W., Oldham, J. M., and Tulis, E. H. (1982). Tulis. Familial transmission of DSM-III borderline personality disorder. Arch. Gen. Psychiatry 39, 795-799. doi: 10.1001/archpsyc.1982.04290070031007
25. Lucas, L. R., Celen, Z., Tamashiro, K. L., Blanchard, R. J., Blanchard, D. C., Markham, C., et al. (2004). Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior. Neuroscience 124, 449-457. doi: 10.1016/j.neuroscience.2003.12.009
26. Luty, S. E., Carter, J. D., McKenzie, J. M., Rae, A. M., Frampton, C. M., Mulder, R. T., et al. (2007). Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br. J. Psychiatry 190, 496-502. doi: 10.1192/bjp.bp.106.024729
27. Montgomery, S. A., and Asberg, M. (1979). A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382-389. doi: 10.1192/bjp.134.4.382
28. Ni, X., Bismil, R., Chan, K., Sicard, T., Bulgin, N., McMain, S., et al. (2006a). Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neurosci. Lett. 408, 214-219. doi: 10.1016/j.neulet.2006.09.002
29. Ni, X., Chan, K., Bulgin, N., Sicard, T., Bismil, R., McMain, S., et al. (2006b). Association between serotonin transporter gene and borderline personality disorder. J. Psychiatr. Res. 40, 448-453. doi: 10.1016/j.jpsychires.2006.03.010
30. Ni, X., Chan, D., Chan, K., McMain, S., and Kennedy, J. L. (2009). Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 128-133. doi: 10.1016/j.pnpbp.2008.10.022
31. Oquendo, M. A., and Mann, J. J. (2000). The biology of impulsivity and suicidality. Psychiatr. Clin. North Am. 23, 11-25. doi: 10.1016/S0193-953X(05)70140-4
32. Paris, J., Zweig-Frank, H., Kin, N. M., Schwartz, G., Steiger, H., and Nair, N. P. (2004). Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res. 121, 239-252. doi: 10.1016/S0165-1781(03)00237-3
33. Parker, G. (1979). Parental characteristics in relation to depressive disorders. Br. J. Psychiatry 134, 138-147. doi: 10.1192/bjp.134.2.138
34. Parker, G., Hadzi-Pavlovic, D., Wilhelm, K., Hickie, I., Brodaty, H., Boyce, P., et al. (1994). Defining melancholia: properties of a refined sign-based measure. Br. J. Psychiatry 164, 216-226. doi: 10.1192/bjp.164.3.316
35. Pascual, J. C., Soler, J., Baiget, M., Cortes, A., Menoyo, A., Barrachina, J., et al. (2007). Association between the serotonin transporter gene and personality traits in borderline personality disorder patients evaluated with Zuckerman-Zuhlman personality questionnaire (ZKPQ). Actas Esp. Psiquiatr. 35, 382-386.
36. Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., and Feinstein, A. R. (1996). A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 49, 1373-1379. doi: 10.1016/S0895-4356(96)00236-3
37. Phillips, R. G., and LeDoux, J. E. (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274-285. doi: 10.1037/0735-7044.106.2.274
38. Retz, W., Retz-Junginger, P., Supprian, T., Thome, J., and Rosler, M. (2004). Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav. Sci. Law 22, 415-425. doi: 10.1002/bsl.589
39. Rodriguiz, R. M., Chu, R., Caron, M. G., and Wetsel, W. C. (2004). Aberrant responses in social interaction of dopamine transporter knockout mice. Behav. Brain Res. 148, 185-198. doi: 10.1016/S0166-4328(03)00187-6
40. Serretti, A., Mandelli, L., Giegling, I., Schneider, B., Hartmann, A. M., Schnabel, A., et al. (2007). HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 291-299. doi: 10.1002/ajmg.b.30432
41. Shi, Y. Y., and He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97-98. doi: 10.1038/sj.cr.7290272
42. Soloff, P. H., Lynch, K. G., Kelly, T. M., Malone, K. M., and Mann, J. J. (2000a). Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am. J. Psychiatry 157, 601-618. doi: 10.1176/appi.ajp.157.4.601
43. Soloff, P. H., Meltzer, C. C., Greer, P. J., Constantine, D., and Kelly, T. M. (2000b). A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol. Psychiatry 47, 540-547. doi: 10.1016/S0006-3223(99)00202-4
44. Soloff, P. H., Price, J. C., Meltzer, C. C., Fabio, A., Frank, G. K., and Kaye, W. H. (2007). 5HT2A receptor binding is increased in borderline personality disorder. Biol. Psychiatry 62, 580-587. doi: 10.1016/j.biopsych.2006.10.022
45. Spitzer, M. (1987). [Clinical aspects and practical applications of DSM-III]. Psychiatr. Prax 14, 212-217.
46. Spitzer, R. L., Williams, J. B., Gibbon, M., and First, M. B. (1992). The Structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 49, 624-629. doi: 10.1001/archpsyc.1992.01820080032005
47. Sullivan, P. F., Fifield, W. J., Kennedy, M. A., Mulder, R. T., Sellman, J. D., and Joyce, P. R. (1997). Novelty seeking and a dopamine transporter gene polymorphism (DAT1). Biol. Psychiatry 42, 1070-1072. doi: 10.1016/S0006-3223(97)00346-6
48. Svrakic, D. M., Whitehead, C., Przybeck, T. R., and Cloninger, C. R. (1993). Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch. Gen. Psychiatry 50, 991-999. doi: 10.1001/archpsyc.1993.01820240075009
49. Torgersen, S. (2000). Genetics of patients with borderline personality disorder. Psychiatr. Clin. North Am. 23, 1-9. doi: 10.1016/S0193-953X(05)70139-8
50. Torgersen, S., Lygren, S., Oien, P. A., Skre, I., Onstad, S., Edvardsen, J., et al. (2000). A twin study of personality disorders. Compr. Psychiatry 41, 416-425. doi: 10.1053/comp.2000.16560
51. Zanarini, M. C., Frankenburg, F. R., Yong, L., Raviola, G., Bradford Reich, D., Hennen, J., et al. (2004). Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J. Pers. Disord. 18, 439-447. doi: 10.1521/pedi.18.5.439.51327
52. Zetzsche, T., Preuss, U. W., Bondy, B., Frodl, T., Zill, P., Schmitt, G., et al. (2008). 5-HT1A receptor gene C-1019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain Behav. 7, 306-313. doi: 10.1111/j.1601-183X.2007.00353.x